Skip to main content

CORRECTION article

Front. Pharmacol., 13 November 2023
Sec. Gastrointestinal and Hepatic Pharmacology

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes

Chao Jin,&#x;Chao Jin1,2Bei-Bei Gao&#x;Bei-Bei Gao3Wen-Jing Zhou,Wen-Jing Zhou1,2Bao-Jing ZhaoBao-Jing Zhao4Xing FangXing Fang5Chun-Lan Yang,Chun-Lan Yang1,2Xiao-Hua Wang,Xiao-Hua Wang1,2Quan Xia,Quan Xia1,2Ting-Ting Liu,
Ting-Ting Liu1,2*
  • 1School of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, China
  • 2The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, China
  • 3Department of Pharmacy, The Second Hospital of Anhui Medical University, Hefei, China
  • 4Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
  • 5Department of Pharmacy, The Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, China

A Corrigendum on
Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes

by Jin C, Gao B-B, Zhou W-J, Zhao B-J, Fang X, Yang C-L, Wang X-H, Xia Q and Liu T-T (2022). Front. Pharmacol. 13:972397. doi: 10.3389/fphar.2022.972397

In the published article, there was an error in affiliations 1, 2. Instead of “1School of Pharmacy, Anhui Medical University, Hefei, China, 2Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, China,” it should be “1School of Pharmacy, the First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, China, 2The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: hydroxychloroquine, autoimmune hepatitis, regulatory T cells, glycolipid metabolism, G protein-coupled receptor kinase 2, PI3K-AKT axis

Citation: Jin C, Gao B-B, Zhou W-J, Zhao B-J, Fang X, Yang C-L, Wang X-H, Xia Q and Liu T-T (2023) Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes. Front. Pharmacol. 14:1322549. doi: 10.3389/fphar.2023.1322549

Received: 16 October 2023; Accepted: 31 October 2023;
Published: 13 November 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Jin, Gao, Zhou, Zhao, Fang, Yang, Wang, Xia and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ting-Ting Liu, bGl1dGluZ3RpbmdAYWhtdS5lZHUuY24=

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.